Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,976 | 743 | 99.7% |
| Education | $43.90 | 9 | 0.3% |
| Travel and Lodging | $3.94 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,094 | 83 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,354 | 55 | $0 (2023) |
| Lilly USA, LLC | $1,288 | 80 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,281 | 56 | $0 (2021) |
| Novo Nordisk Inc | $1,108 | 77 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,005 | 68 | $0 (2023) |
| Amgen Inc. | $795.63 | 31 | $0 (2022) |
| GlaxoSmithKline, LLC. | $640.87 | 42 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $602.89 | 16 | $0 (2023) |
| Amarin Pharma Inc. | $558.50 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,116 | 60 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($177.71) |
| 2022 | $2,254 | 98 | Amgen Inc. ($272.60) |
| 2021 | $1,694 | 69 | Biohaven Pharmaceuticals, Inc. ($222.88) |
| 2020 | $1,104 | 48 | AstraZeneca Pharmaceuticals LP ($219.79) |
| 2019 | $3,573 | 174 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($604.79) |
| 2018 | $3,455 | 177 | AstraZeneca Pharmaceuticals LP ($834.92) |
| 2017 | $3,828 | 127 | AstraZeneca Pharmaceuticals LP ($1,267) |
All Payment Transactions
753 individual payment records from CMS Open Payments — Page 3 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Oncology | ||||||
| 01/25/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Endocrinology | ||||||
| 01/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: Neuroscience | ||||||
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardio-renal | ||||||
| 01/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: INSOMNIA | ||||||
| 01/10/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/09/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Diabetes | ||||||
| 01/04/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 12/27/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes Care | ||||||
| 12/16/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Diabetes Care | ||||||
| 12/14/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $129.03 | General |
| Category: Diabetes Care | ||||||
| 12/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Gastroenterology | ||||||
| 12/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardio-renal | ||||||
| 11/17/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: Inflammation | ||||||
| 11/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardio-renal | ||||||
| 11/09/2022 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $96.40 | General |
| Category: Bone Health | ||||||
| 11/09/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Neuroscience | ||||||
| 11/07/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: VACCINES | ||||||
| 11/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Cardio-renal | ||||||
| 10/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $115.83 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 312 | 442 | $95,390 | $26,219 |
| 2022 | 11 | 642 | 1,015 | $208,997 | $78,142 |
| 2021 | 11 | 558 | 916 | $173,798 | $40,000 |
| 2020 | 12 | 758 | 1,114 | $169,328 | $61,465 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 193 | 296 | $72,816 | $18,517 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 96 | $16,608 | $4,934 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $3,502 | $2,038 | 58.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 22 | $2,332 | $706.01 | 30.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 11 | $132.00 | $24.20 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 564 | $133,386 | $42,113 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $15,656 | $9,450 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 150 | $25,096 | $8,372 | 33.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 29 | 29 | $16,443 | $8,069 | 49.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 26 | 26 | $8,034 | $4,147 | 51.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 40 | 40 | $4,200 | $2,810 | 66.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 30 | $3,082 | $1,014 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $972.00 | $952.56 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 27 | 27 | $729.00 | $716.04 | 98.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 14 | 16 | $1,147 | $451.17 | 39.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 21 | $252.00 | $46.45 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 263 | 578 | $131,206 | $25,217 | 19.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 116 | $18,444 | $4,943 | 26.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 20 | 20 | $3,280 | $2,500 | 76.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 34 | 36 | $3,780 | $2,375 | 62.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $6,798 | $1,814 | 26.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 19 | 19 | $5,871 | $984.92 | 16.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 18 | $1,782 | $716.16 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 35 | 37 | $999.00 | $582.16 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 29 | 29 | $783.00 | $457.15 | 58.4% |
About Dr. Charles Womack, M.D
Dr. Charles Womack, M.D is a Family Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205810702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Womack, M.D has received a total of $17,024 in payments from pharmaceutical and medical device companies, with $1,116 received in 2023. These payments were reported across 753 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($16,976).
As a Medicare-enrolled provider, Womack has provided services to 2,270 Medicare beneficiaries, totaling 3,487 services with total Medicare billing of $205,826. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Oklahoma City, OK
- Active Since 11/30/2005
- Last Updated 09/14/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1205810702
Products in Payments
- FARXIGA (Drug) $1,595
- JARDIANCE (Drug) $925.87
- XIFAXAN (Drug) $886.02
- Vascepa (Drug) $558.50
- TRELEGY ELLIPTA (Drug) $438.87
- JANUVIA (Drug) $433.04
- BEVESPI AEROSPHERE (Drug) $432.76
- SYMBICORT (Drug) $424.52
- Otezla (Drug) $397.82
- Ozempic (Drug) $388.92
- TRULICITY (Drug) $384.14
- NURTEC ODT (Drug) $362.53
- INVOKANA (Drug) $354.90
- TRULANCE (Drug) $347.41
- Kerendia (Drug) $342.66
- Tresiba (Drug) $333.40
- Movantik (Drug) $280.71
- EMGALITY (Drug) $255.10
- Aimovig (Biological) $253.98
- TOUJEO (Biological) $234.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oklahoma City
Melinda Cail, M.d, M.D
Family Medicine — Payments: $96,253
Dr. Carl Griffin, M.d, M.D
Family Medicine — Payments: $58,692
Dr. John Pittman, M.d, M.D
Family Medicine — Payments: $58,571
Dr. Tyler Phillips, Md, MD
Family Medicine — Payments: $33,490
Terrence Truong, M.d, M.D
Family Medicine — Payments: $31,884
Jonathan Knox, D.o, D.O
Family Medicine — Payments: $23,297